Matt Phipps
Stock Analyst at William Blair
(4.17)
# 1,576
Out of 4,692 analysts
602
Total ratings
48.8%
Success rate
6.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TENX Tenax Therapeutics | Maintained: Hold | n/a | $1.84 | - | 20 | Aug 31, 2026 | |
| AMGN Amgen | Reiterated: Buy | n/a | $429.88 | - | 40 | Aug 27, 2026 | |
| INCY Incyte | Maintained: Hold | n/a | $123.22 | - | 49 | Aug 19, 2026 | |
| CLYM Climb Bio | Maintained: Buy | n/a | $13.73 | - | 14 | Aug 19, 2026 | |
| ARGX argenx SE | Maintained: Buy | n/a | $1,031.66 | - | 14 | Aug 17, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | n/a | $66.81 | - | 61 | Aug 14, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | n/a | $22.07 | - | 24 | Aug 13, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | n/a | $18.22 | - | 20 | Aug 13, 2026 | |
| AUTL Autolus Therapeutics | Reiterated: Buy | n/a | $2.35 | - | 42 | Aug 11, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $33.16 | - | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.54 | - | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.62 | - | 21 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.36 | - | 6 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.39 | - | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $12.66 | - | 17 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $121.82 | - | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.27 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.34 | - | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3897 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.10 | - | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.08 | - | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $256.42 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.7114 | - | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $198.52 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $60.36 | +93.44% | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $105.61 | - | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.61 | n/a | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.09 | n/a | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $544.52 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $140.34 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.09 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.47 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $15.80 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7499 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $152.59 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.90 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0003 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.02 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $216.65 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $71.38 | n/a | 1 | Jun 11, 2021 |
Tenax Therapeutics
Aug 31, 2026
Maintained: Hold
Price Target: n/a
Current: $1.84
Upside: -
Amgen
Aug 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $429.88
Upside: -
Incyte
Aug 19, 2026
Maintained: Hold
Price Target: n/a
Current: $123.22
Upside: -
Climb Bio
Aug 19, 2026
Maintained: Buy
Price Target: n/a
Current: $13.73
Upside: -
argenx SE
Aug 17, 2026
Maintained: Buy
Price Target: n/a
Current: $1,031.66
Upside: -
Bristol-Myers Squibb Company
Aug 14, 2026
Maintained: Hold
Price Target: n/a
Current: $66.81
Upside: -
Cullinan Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.07
Upside: -
Janux Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: n/a
Current: $18.22
Upside: -
Autolus Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.35
Upside: -
Genmab
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.16
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.54
Upside: -
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.62
Upside: -
Aug 10, 2026
Maintained: Buy
Price Target: n/a
Current: $21.36
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.39
Upside: -
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $12.66
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $121.82
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $27.27
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.34
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.3897
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $5.10
Upside: -
Aug 4, 2026
Maintained: Hold
Price Target: n/a
Current: $11.08
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $256.42
Upside: -
Jun 1, 2026
Maintained: Hold
Price Target: n/a
Current: $0.7114
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $198.52
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $60.36
Upside: +93.44%
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $105.61
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $7.61
Upside: n/a
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $11.09
Upside: n/a
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $544.52
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $140.34
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.09
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.47
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $15.80
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.7499
Upside: n/a
Jan 3, 2022
Maintained: Buy
Price Target: n/a
Current: $152.59
Upside: n/a
Dec 7, 2021
Maintained: Buy
Price Target: n/a
Current: $8.90
Upside: n/a
Dec 7, 2021
Maintained: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: n/a
Current: $1.02
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $216.65
Upside: n/a
Jun 11, 2021
Maintained: Buy
Price Target: n/a
Current: $71.38
Upside: n/a